ORGENESIS INC
ORGS Real Time Price USDRecent trades of ORGS by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ORGS's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Methods of transdifferentiation and methods of use thereof Apr. 04, 2023
-
Patent Title: Prophylactic protection against viral infections May. 17, 2022
-
Patent Title: Transdifferentiated cell populations and methods of use thereof Apr. 13, 2021
-
Patent Title: Cell populations, methods of transdifferentiation and methods of use thereof Mar. 16, 2021
-
Patent Title: Prophylactic protection against viral infections, particularly hiv Nov. 17, 2020
-
Patent Title: Methods of transdifferentiation and methods of use thereof Jun. 02, 2020
-
Patent Title: Methods of transdifferentiation and methods of use thereof Jan. 15, 2019
-
Patent Title: Cell populations, methods of transdifferentiation and methods of use thereof May. 29, 2018
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of ORGS in WallStreetBets Daily Discussion
Recent insights relating to ORGS
Recent picks made for ORGS stock on CNBC
ETFs with the largest estimated holdings in ORGS
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ORGS Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.